Patient with diabetes and peripheral neuropathy (often Risk 1 or 2) presents with a foot that is warm, swollen, and erythematous — typically unilateral. May follow recent activity, minor trauma, or unaccustomed walking. Pain is often less than the appearance would suggest because of the underlying neuropathy. Temperature differential between affected and contralateral foot is often >2°C. The early phase is sometimes called "acute Charcot" or Eichenholtz Stage 0/1.
Common Pitfalls & Don't-Miss Diagnoses
By the end of this lesson, the learner will be able to:
- Recognize the classic presentation of six high-stakes foot-care diagnoses where missed recognition leads to limb-threatening or life-threatening outcomes.
- Distinguish each diagnosis from the more common condition it's most often confused with.
- Identify the red flags that should trigger urgent escalation rather than continued routine care.
- Apply the appropriate level of urgency for each diagnosis (ER, urgent specialty referral, sooner-than-routine follow-up).
- Recognize and counter the cognitive pitfalls that contribute to missed diagnoses in routine foot care visits.
Foot care nurses see hundreds of "stable" patients between rare "don't-miss" presentations — and the missed diagnosis usually doesn't look dramatic at first glance. Charcot looks like cellulitis. Subungual melanoma looks like a hematoma. A covered ulcer looks like a callus. The cost of recognizing these correctly is small; the cost of missing them is large. This lesson covers the six diagnoses most worth knowing well, the patterns that distinguish them, and the cognitive habits that protect you from the most common recognition errors.
Charcot: No fever. Normal or near-normal WBC. No leukocytosis. Hyperglycemia not necessarily present. History of activity/injury common. Often there is no skin break — erythema is generalized, not tracking from a wound.
Cellulitis: Often has fever, leukocytosis, source of infection (wound, ulcer, fissure). Erythema typically radiates from a portal of entry. Patient appears systemically unwell.
Both can coexist. When uncertain, treat as both possibilities until imaging and labs clarify.
- Hot, red, swollen foot in a neuropathic diabetic patient WITHOUT systemic infection signs
- Temperature differential >2°C between feet
- Recent unaccustomed activity or minor trauma
- Pain mismatch (less pain than the appearance suggests, due to neuropathy)
- No obvious wound or portal of entry for infection
- Immediate offloading — non-weight-bearing on the affected foot
- Urgent referral to podiatry, orthopedic surgery, or wound care for evaluation; may need total contact cast
- Imaging (X-ray initial, MRI more sensitive in early disease) — orchestrated by the receiving specialist
- Communicate to PCP same day; document concern for Charcot vs. cellulitis
- Patient education: do NOT walk on this foot until specialist clears; the activity is what destroys the architecture
Pain (sudden, severe), Pallor, Pulselessness, Paresthesia, Paralysis (late finding), Poikilothermia (cold to touch). Acute presentation is hours-to-days; chronic critical limb ischemia presents as rest pain (especially nocturnal, relieved by dependency), tissue loss, or gangrene developing over weeks.
Acute: Sudden onset (hours), severe pain, cold/pale, pulses absent, asymmetric. Usually embolic (cardiac source) or thrombotic (on top of pre-existing PAD). Time-critical emergency.
Chronic critical limb ischemia: Rest pain (worse with elevation, better hanging foot off bed), non-healing wounds, gangrene. Develops over weeks to months on a background of PAD. Urgent but not minute-by-minute.
- Sudden onset of severe foot/leg pain with cold pale extremity
- Absent pulses (not just weak — absent)
- Rest pain that wakes the patient at night
- New-onset tissue loss or gangrene
- Asymmetric findings (one foot clearly different from the other)
- Acute (hours): IMMEDIATE ER referral. Do not wait for outpatient vascular. Time-sensitive revascularization may save the limb.
- Chronic critical limb ischemia (rest pain, tissue loss): Urgent vascular referral within days; communicate to PCP same day
- Document findings precisely: pulses, temperature, color, pain character, time of onset
- Do not apply compression, do not elevate the foot (counterintuitive — can worsen ischemia)
- Patient education on calling for help if symptoms worsen between visits
A — Age (any age can be affected, but middle age and older are most common)
B — Brown/Black band with breadth > 3 mm and irregular borders
C — Change in size, color, or shape; or failure to grow out over weeks
D — Digit involved (thumb and great toe most common)
E — Extension of pigment to nail fold or surrounding skin (Hutchinson's sign)
F — Family history of melanoma, or personal history of dysplastic nevi
Hematoma: History of trauma (or repeated minor trauma in athletes, anticoagulated patients). Uniform brown-purple-red. Grows OUT with the nail — proximal edge migrates distally over weeks as the nail grows. No extension to nail fold. Usually single digit, often great toe in runners.
Melanoma: Often no clear trauma history. Color may be irregular (brown to black to gray). Does NOT grow out — pigmentation is being produced at the matrix continuously. Extension to nail fold (Hutchinson's sign) is highly concerning. May have associated nail plate dystrophy.
The single most useful question: "Has it been growing out with the nail, or staying in the same position?"
- Pigmented band > 3 mm wide with irregular borders
- Pigmentation that hasn't grown out over weeks to months
- Hutchinson's sign — pigment extending to the nail fold or surrounding skin
- Single-digit involvement (especially thumb or great toe) in the absence of clear trauma
- New pigmentation in a patient over 50
- Color variation within the band (not uniform)
- Refer urgently to dermatology for biopsy — same week if possible
- Do not "wait and see" past 4–6 weeks if features are concerning
- Document clearly with measurements (band width, length, location, color description) and ideally clinical photography
- Patient education on what melanoma is and why prompt evaluation matters; avoid alarming language while conveying urgency
- Communicate to PCP for tracking of dermatology follow-up
Long-standing callus, often forefoot or plantar, in a diabetic neuropathic patient. During routine reduction, you encounter dark discoloration in deeper layers, drainage (serous, purulent, or hemorrhagic), fluctuance, or a break in skin integrity at the edge. May have a halo of erythema around the callus on initial inspection. Malodor when reduced is concerning.
Simple callus: Uniform yellowish thickened skin. No discoloration in deeper layers when reduced. Reduces cleanly to healthy pink dermis. No drainage, no malodor, no halo.
Covered ulcer: Surface looks like a callus. During reduction, deeper layers reveal dark patches, blood-tinged or purulent drainage, fluctuance, or skin break. Edge of the lesion may be undermined.
The cardinal teaching point from Module 5 Lesson 2: any unexpected finding during reduction is a stop signal, not a curiosity to investigate further.
- Dark discoloration appearing in deeper callus layers during reduction
- Drainage of any kind during reduction (serous, purulent, blood-tinged)
- Fluctuance on palpation
- Skin break at the edge of the callus
- Halo of erythema around the lesion
- Malodor when reducing
- Pain on probing in a patient who normally has no pain (sudden return of sensation often = inflammation/infection)
- STOP reduction immediately — do not continue to expose what's underneath
- Examine gently for skin integrity, fluctuance, drainage, undermining
- Apply a clean dressing
- Document thoroughly with photo (per facility policy) and detailed findings
- Urgent referral to wound care or podiatry — same week, not next routine visit
- Communicate to PCP same day
- Patient education on signs of infection at home; sooner-than-routine nursing follow-up
Grade 1 (uninfected): No purulence or signs of inflammation.
Grade 2 (mild): Local infection — erythema 0.5–2 cm around wound, purulence, warmth.
Grade 3 (moderate): Erythema >2 cm, deeper structures involved (fascia, muscle, joint, bone), but no systemic signs.
Grade 4 (severe): Systemic signs (SIRS) — fever, hypotension, tachycardia, mental status change, marked hyperglycemia, leukocytosis.
In a diabetic neuropathic patient, severe infection may present with: minimal pain, mild-appearing skin findings, but rapid progression in 24–48 hours, hyperglycemia disproportionate to usual, exposed bone (probe-to-bone test positive), gas in tissue (crepitus), undermining tracks, foul odor.
The probe-to-bone test: a sterile blunt probe inserted into the wound that touches bone has high specificity for osteomyelitis in diabetic foot ulcers. Positive probe-to-bone in a Grade 3+ infection = imaging needed.
- Rapid progression — wound looks worse in 24–48 hours
- Spreading erythema beyond 2 cm from wound edge
- Probe-to-bone positive
- Crepitus, gas in tissues
- Hyperglycemia out of proportion to usual
- Any systemic signs: fever, tachycardia, hypotension, mental status change
- Foul odor, deep undermining, tracks
- Severe (Grade 4): IMMEDIATE ER referral. Empiric IV antibiotics, surgical evaluation, imaging
- Moderate (Grade 3): Same-day or next-day urgent referral to podiatry/wound care/infectious disease
- Imaging often needed (X-ray for gas, MRI for osteomyelitis, CT for deep collections)
- Probe-to-bone test if wound depth and skin integrity allow
- Document precisely: erythema dimensions, depth, drainage character, probe-to-bone result, systemic signs
- Communicate to PCP and ensure handoff to receiving team
The cardinal sign is pain out of proportion to exam findings — the patient is in severe distress, but the skin doesn't look as bad as the pain suggests. The pain may extend beyond the visibly affected area. Rapid progression over hours, not days. Skin appearance evolves: erythema → dusky/violet/gray discoloration → bullae (often hemorrhagic) → frank necrosis (purple to black). Crepitus may be present (gas in tissues, classic for clostridial or polymicrobial infections). Systemic toxicity: fever, tachycardia, hypotension, mental status changes.
Simple cellulitis: Tender but not severe pain. Erythema is tender to palpation but not "out of proportion." Slower progression (over days). Borders relatively well-defined. Patient may have fever but is not toxic-appearing.
Necrotizing infection: Pain dramatically exceeds what the skin would suggest. Rapid progression (hours). Dusky/violet discoloration. Hemorrhagic bullae. Crepitus may be present. Patient is toxic-appearing — looks systemically unwell.
The single most useful sign: "the patient looks worse than the foot does."
- Pain out of proportion to exam findings — the cardinal sign
- Rapid progression in hours
- Dusky, violet, or gray skin discoloration
- Hemorrhagic or clear bullae forming
- Crepitus on palpation (gas)
- Systemic toxicity: fever, hypotension, tachycardia, mental status change
- Patient looks worse than the foot does
- IMMEDIATE ER referral. This is a surgical emergency. Do not wait, do not refer to outpatient.
- Communicate the suspicion directly to the receiving team — necrotizing fasciitis suspected
- Document time of onset, evolution, all findings
- Do NOT debride or attempt local interventions
- If patient cannot transport themselves, call EMS
Common Pitfalls in Pattern Recognition
Beyond knowing the diagnoses themselves, certain cognitive habits make missed recognition more likely. Awareness of these patterns is part of the protection against them.
- Diagnostic anchoring. Assuming this visit is the same as last visit because the patient looks similar. The first thing to check is whether anything is actually different from baseline.
- Attribution errors. Attributing new findings to known conditions ("oh, that's just his diabetes" or "that's her usual swelling"). Each new finding deserves its own consideration before being attributed to an existing diagnosis.
- The "just a callus" mindset. Long-standing findings can develop new pathology. A callus that's been there for 6 months doesn't get a free pass on inspection.
- Confirmation bias from referring notes. If the referring clinician wrote "stable foot" or "routine care," that frames your perception. Read with curiosity, not as a closed conclusion.
- Skipping baseline comparison. Trends matter more than single snapshots. If you don't know what the foot looked like last visit, you can't recognize what's changed.
- Trusting verbal report alone. "No pain" in a neuropathic patient is not reassuring. The absence of a symptom that depends on intact sensation is meaningless without intact sensation.
- Failing the un-emphasized differential. When a finding looks like a common diagnosis, also ask: what could this look like that's worse? The differential should always include the don't-miss diagnosis even if unlikely.
- Vague documentation. "Intact," "stable," "WNL" without specifics obscures findings — especially as multiple clinicians review the chart over time. Specific findings (with measurements) are protective.
The cost of an unnecessary referral is a clinic visit and the patient's time. The cost of a missed don't-miss diagnosis is a limb, sometimes a life. The asymmetry is enormous — and it's the right justification for erring toward escalation when the picture is uncertain.
If the question in your head is "is this Charcot or cellulitis?" — refer to confirm. If you're wondering whether that pigmented band is a hematoma or something more — refer to confirm. If something feels different about a long-standing callus during reduction — stop and confirm. The system is designed for this kind of "rule out" workup; you are not asking too much of it by using it appropriately.
Foot care nurses who maintain this default tend to catch the rare cases earlier — and the cumulative effect across years of practice is meaningful. The reverse default — trusting reassurance and waiting for unambiguous presentation — is the one that produces the cases everyone remembers.
Quick Reference: All Six Diagnoses
A summary card you can return to. The most useful columns when you're trying to recognize one of these in a real visit.
Many foot care nurses keep a printed version of this reference at their workstation. The cognitive load of recall is highest when you're seeing a tricky finding in real time; an external reference reduces the chance of attribution error or pattern miss in the moment.
Ready to test your recognition? Take the 5-question knowledge check covering all six don't-miss diagnoses.
Module 9 brought together the principles taught throughout the course — procedure demonstrations, integrated case studies, and high-stakes recognition. Up next: Module 10 — Business, Professional Development & Final Assessment.
This lesson is provided for professional continuing education and informational purposes only. It is intended to support knowledge development in foot care nursing and does not constitute clinical advice, legal advice, or regulatory guidance.
This course content does not replace, supersede, or serve as a substitute for: the California Board of Registered Nursing (BRN) Nurse Practice Act and current BRN regulations (rn.ca.gov); California state laws and health codes governing nursing practice; county and local public health department requirements applicable to your practice setting; your facility's policies, protocols, and procedures; or your individual scope of practice as defined by your nursing license, credentials, and employer authorization.
Verify before practicing. Clinical guidelines, regulatory requirements, and scope-of-practice rules change over time. You are responsible for verifying all clinical information against current BRN regulations, California law, county requirements, and your facility's policies before applying any content from this course in practice. When in doubt, consult your supervisor, your facility's compliance team, or the California Board of Registered Nursing directly at rn.ca.gov.
References
- International Working Group on the Diabetic Foot (IWGDF). IWGDF Guidelines on the Prevention and Management of Diabetes-Related Foot Disease. 2023.
- Senneville É, Albalawi Z, van Asten SA, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF/IDSA). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3687.
- Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123–2129. (Foundational reference for Charcot recognition and management.)
- Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease. Circulation. 2017;135(12):e726–e779.
- Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. Journal of the American Academy of Dermatology. 2000;42(2 Pt 1):269–274. (ABCDEF rule and Hutchinson's sign for subungual melanoma.)
- Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Critical Care Medicine. 2004;32(7):1535–1541.
- Wound, Ostomy and Continence Nurses Society (WOCN). Guideline for Management of Wounds in Patients with Lower-Extremity Neuropathic Disease. 2012 (and subsequent updates).
- American Diabetes Association. Standards of Care in Diabetes — Foot Care. Diabetes Care. 2024;47(Suppl 1).

